SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 242 filers reported holding SEATTLE GENETICS INC in Q3 2016. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $329,000 | +5.1% | 6,042 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $313,000 | -15.6% | 6,042 | +2.4% | 0.00% | 0.0% |
Q1 2017 | $371,000 | +10.7% | 5,901 | -7.0% | 0.00% | 0.0% |
Q4 2016 | $335,000 | +2.8% | 6,342 | +5.2% | 0.00% | -33.3% |
Q3 2016 | $326,000 | +35.8% | 6,031 | +1.5% | 0.00% | +50.0% |
Q2 2016 | $240,000 | +15.4% | 5,942 | +0.4% | 0.00% | 0.0% |
Q1 2016 | $208,000 | -23.0% | 5,917 | -1.7% | 0.00% | -33.3% |
Q4 2015 | $270,000 | +27.4% | 6,017 | +9.7% | 0.00% | +50.0% |
Q3 2015 | $212,000 | -20.6% | 5,487 | -0.4% | 0.00% | -33.3% |
Q2 2015 | $267,000 | -1.8% | 5,507 | -24.7% | 0.00% | 0.0% |
Q3 2014 | $272,000 | -95.5% | 7,317 | -95.4% | 0.00% | -95.9% |
Q2 2014 | $6,112,000 | -11.6% | 159,801 | +5.3% | 0.07% | -22.9% |
Q1 2014 | $6,917,000 | +14.2% | 151,826 | 0.0% | 0.10% | +9.1% |
Q4 2013 | $6,056,000 | -18.2% | 151,826 | -10.1% | 0.09% | -26.7% |
Q3 2013 | $7,405,000 | +25.6% | 168,951 | -9.9% | 0.12% | +15.4% |
Q2 2013 | $5,898,000 | – | 187,476 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |